Transgenic mice over-expressing et-1 in the endothelial cells develop systemic hypertension with altered vascular reactivity

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Leung, Justin Wai Chung ^a   Wong, Wing Tak ^b   Koon, Hon Wai ^a   Mo, Fong Ming ^a   Tam, Sidney ^a   Huang, Yu ^b   Vanhoutte, Paul M ^a   Chung, Stephen Sum Man ^c   Chung, Sookja Kim ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c BNU HKBU UNITED INTERNATIONAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY RESISTANCE; ARTICLE; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; CONTROLLED STUDY; DISEASE SEVERITY; ELECTROCARDIOGRAM; ENDOTHELIUM CELL; HEART LEFT VENTRICLE HYPERTROPHY; HYPERTENSION; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LUNG BLOOD VESSEL; MALE; MEAN ARTERIAL PRESSURE; MESENTERIC ARTERY; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SYSTOLIC BLOOD PRESSURE; TRANSGENIC MOUSE; UPREGULATION; UREA BLOOD LEVEL; ANIMAL; ARTERY; BLOOD PRESSURE; ELECTROCARDIOGRAPHY; GENETICS; HEART; IN SITU HYBRIDIZATION; IN VITRO STUDY; LUNG; METABOLISM; ORGAN SIZE; PHYSIOLOGY;

MUS; MUS MUSCULUS;

ANIMALS; ARTERIES; BLOOD PRESSURE; ELECTROCARDIOGRAPHY; ENDOTHELIAL CELLS; ENDOTHELIN-1; HEART; HYPERTENSION; IN SITU HYBRIDIZATION; LUNG; MALE; MICE; MICE, TRANSGENIC; ORGAN SIZE;

EID: 80855133584     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026994     Document Type: Article

References (37)

1. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, et al. (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415.
2. Liu JJ, Casley D, Wojta J, Gallicchio M, Dauer R, et al. (1994) Effects of calcium- and ETA-receptor antagonists on endothelin-induced vasoconstriction and levels of endothelin in the human internal mammary artery. Clin Exp Pharmacol Physiol 21: 49-57.
3. Hirata Y, Emori T, Eguchi S, Kanno K, Imai T, et al. (1993) Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells. J Clin Invest 91: 1367-1373.
4. Yanagisawa M, Kurihara H, Kimura S, Goto K, Masaki T, (1988) A novel peptide vasoconstrictor, endothelin, is produced by vascular endothelium and modulates smooth muscle Ca2+ channels. J Hypertens Suppl 6: S188-191.
5. McMahon EG, Palomo MA, Moore WM, (1991) Phosphoramidon blocks the pressor activity of big endothelin[1-39] and lowers blood pressure in spontaneously hypertensive rats. J Cardiovasc Pharmacol 17 (Suppl 7): S29-S33.
6. Day R, Lariviere R, Schiffrin EL, (1995) In situ hybridization shows increased endothelin-1 mRNA levels in endothelial cells of blood vessels of deoxycorticosterone acetate-salt hypertensive rats. Am J Hypertens 8: 294-300.
7. Lariviere R, Day R, Schiffrin EL, (1993) Increased expression of endothelin-1 gene in blood vessels of deoxycorticosterone acetate-salt hypertensive rats. Hypertension 21: 916-920.
8. Schiffrin EL, Lariviere R, Li JS, Sventek P, Touyz RM, (1995) Deoxycorticosterone acetate plus salt induces overexpression of vascular endothelin-1 and severe vascular hypertrophy in spontaneously hypertensive rats. Hypertension 25: 769-773.
9. Sharifi AM, He G, Touyz RM, Schiffrin EL, (1998) Vascular endothelin-1 expression and effect of an endothelin ETA antagonist on structure and function of small arteries from stroke-prone spontaneously hypertensive rats. J Cardiovasc Pharmacol 31 (Suppl 1): S309-312.
10. Schiffrin EL, Sventek P, Li JS, Turgeon A, Reudelhuber T, (1995) Antihypertensive effect of an endothelin receptor antagonist in DOCA-salt spontaneously hypertensive rats. Br J Pharmacol 115: 1377-1381.
11. Li JS, Turgeon A, Schiffrin EL, (1998) Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats. Am J Hypertens 11: 554-562.
12. d'Uscio LV, Barton M, Shaw S, Moreau P, Luscher TF, (1997) Structure and function of small arteries in salt-induced hypertension: effects of chronic endothelin-subtype-A-receptor blockade. Hypertension 30: 905-911.
13. Schiffrin EL, (1995) Endothelin: potential role in hypertension and vascular hypertrophy. Hypertension 25: 1135-1143.
14. Kurihara Y, Kurihara H, Suzuki H, Kodama T, Maemura K, et al. (1994) Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature 368: 703-710.
15. Hocher B, Thone-Reineke C, Rohmeiss P, Schmager F, Slowinski T, et al. (1997) Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension. J Clin Invest 99: 1380-1389.
16. Shindo T, Kurihara H, Maemura K, Kurihara Y, Ueda O, et al. (2002) Renal damage and salt-dependent hypertension in aged transgenic mice overexpressing endothelin-1. J Mol Med 80: 105-116.
17. Amiri F, Virdis A, Neves MF, Iglarz M, Seidah NG, et al. (2004) Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction. Circulation 110: 2233-2240.
18. Amiri F, Paradis P, Reudelhuber TL, Schiffrin EL, (2008) Vascular inflammation in absence of blood pressure elevation in transgenic murine model overexpressing endothelin-1 in endothelial cells. J Hypertens 26: 1102-1109.
19. Quaschning T, Voss F, Relle K, Kalk P, Vignon-Zellweger N, et al. (2007) Lack of endothelial nitric oxide synthase promotes endothelin-induced hypertension: lessons from endothelin-1 transgenic/endothelial nitric oxide synthase knockout mice. J Am Soc Nephrol 18: 730-740.
20. Gustafsson E, Brakebusch C, Hietanen K, Fassler R, (2001) Tie-1-directed expression of Cre recombinase in endothelial cells of embryoid bodies and transgenic mice. J Cell Sci 114: 671-676.
21. Mansoor AM, Honda M, Saida K, Ishinaga Y, Kuramochi T, et al. (1995) Endothelin induced collagen remodeling in experimental pulmonary hypertension. Biochem Biophys Res Commun 215: 981-986.
22. Galie N, Manes A, Branzi A, (2004) The endothelin system in pulmonary arterial hypertension. Cardiovasc Res 61: 227-237.
23. Hocher B, Schwarz A, Fagan KA, Thone-Reineke C, El Hag K, et al. (2000) Pulmonary fibrosis and chronic lung inflammation in ET-1 transgenic mice. Am J Respir Cell Mol Biol 23: 19-26.
24. Komuro I, Kurihara H, Sugiyama T, Yoshizumi M, Takaku F, et al. (1988) Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells. FEBS Lett 238: 249-252.
25. Schmetterer L, Dallinger S, Bobr B, Selenko N, Eichler HG, et al. (1998) Systemic and renal effects of an ET(A) receptor subtype-specific antagonist in healthy subjects. Br J Pharmacol 124: 930-934.
26. Wong AL, Haroon ZA, Werner S, Dewhirst MW, Greenberg CS, et al. (1997) Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues. Circ Res 81: 567-574.
27. Kisanuki YY, Emoto N, Ohuchi T, Widyantoro B, Yagi K, et al. (2010) Low blood pressure in endothelial cell-specific endothelin 1 knockout mice. Hypertension 56: 121-128.
28. Zachariah PK, Shub C, Sheps SG, Schirger A, Wolf MK, et al. (1988) Correlation between verapamil plasma concentration and P-R prolongation in essential hypertension. J Clin Pharmacol 28: 843-847.
29. Iglarz M, Levy BI, Henrion D, (1998) Chronic endothelin-1-induced changes in vascular reactivity in rat resistance arteries and aorta. Eur J Pharmacol 359: 69-75.
30. Heagerty AM, Aalkjaer C, Bund SJ, Korsgaard N, Mulvany MJ, (1993) Small artery structure in hypertension. Dual processes of remodeling and growth. Hypertension 21: 391-397.
31. Luscher TF, Seo BG, Buhler FR, (1993) Potential role of endothelin in hypertension. Controversy on endothelin in hypertension. Hypertension 21: 752-757.
32. Leung JW, Ho MC, Lo AC, Chung SS, Chung SK, (2004) Endothelial cell-specific over-expression of endothelin- 1 leads to more severe cerebral damage following transient middle cerebral artery occlusion. J Cardiovasc Pharmacol 44 (Suppl 1): S293-S300.
33. Chan TS, Lin CX, Chan WY, Chung SS, Chung SK, (1995) Mouse preproendothelin-1 gene. cDNA cloning, sequence analysis and determination of sites of expression during embryonic development. Eur J Biochem 234: 819-826.
34. Ho MC, Lo AC, Kurihara H, Yu AC, Chung SS, et al. (2001) Endothelin-1 protects astrocytes from hypoxic/ischemic injury. FASEB J 15: 618-626.
35. Tharaux PL, Chatziantoniou C, Casellas D, Fouassier L, Ardaillou R, et al. (1999) Vascular endothelin-1 gene expression and synthesis and effect on renal type I collagen synthesis and nephroangiosclerosis during nitric oxide synthase inhibition in rats. Circulation 99: 2185-2191.
36. Berul CI, Aronovitz MJ, Wang PJ, Mendelsohn ME, (1996) In vivo cardiac electrophysiology studies in the mouse. Circulation 94: 2641-2648.
37. Verdecchia P, Reboldi G, Schillaci G, Borgioni C, Ciucci A, et al. (1999) Circulating insulin and insulin growth factor-1 are independent determinants of left ventricular mass and geometry in essential hypertension. Circulation 100: 1802-1807.